Assessment of Chemotherapy-induced Peripheral Neurotoxicity Using a Point-of-care Nerve Conduction Study Device
NCT04778878
·
clinicaltrials.gov ↗
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Cancer
Interventions
DEVICE:
Mediracer® NCS
Sponsor
Oulu University Hospital